Get the Stockscreener App
1.42
0.70%
0.01
Werewolf Therapeutics Inc stock is traded at $1.42, with a volume of 30,449.
It is up +0.70% in the last 24 hours and up +8.27% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$1.43
Open:
$1.45
24h Volume:
30,449
Relative Volume:
0.10
Market Cap:
$64.94M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-1.3654
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
+8.27%
1M Performance:
+8.27%
6M Performance:
+20.00%
1Y Performance:
-38.46%
1-Day Range:
$1.42
$1.46
1-Week Range:
$1.30
$1.49
52-Week Range:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.42 | 65.39M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.81 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.91 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.50 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
746.55 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.51 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Should you hold or exit Werewolf Therapeutics Inc. nowJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
Value Recap: Does Werewolf Therapeutics Inc. stock have upside surprise potentialMarket Sentiment Summary & Target Return Focused Picks - خودرو بانک
Analysis Recap: Does Werewolf Therapeutics Inc have consistent dividend growth2025 Big Picture & Weekly Market Pulse Updates - خودرو بانک
Using flow based indicators on Werewolf Therapeutics Inc.Analyst Downgrade & Free Reliable Trade Execution Plans - newser.com
Top chart patterns to watch in Werewolf Therapeutics Inc.Market Activity Recap & Real-Time Volume Analysis - newser.com
Using R and stats models for Werewolf Therapeutics Inc. forecastingJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
Candlestick signals on Werewolf Therapeutics Inc. stock todayBond Market & Entry Point Confirmation Signals - newser.com
Published on: 2025-09-14 15:34:20 - newser.com
Applying sector rotation models to Werewolf Therapeutics Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com
Earnings visualization tools for Werewolf Therapeutics Inc.Market Sentiment Summary & Daily Price Action Insights - newser.com
Is Werewolf Therapeutics Inc. building a consolidation baseWeekly Investment Report & Free Reliable Trade Execution Plans - newser.com
Can machine learning forecast Werewolf Therapeutics Inc. recoveryTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Will earnings trigger a reversal in Werewolf Therapeutics Inc.Stop Loss & Verified Short-Term Trading Plans - newser.com
What to do if you’re stuck in Werewolf Therapeutics Inc.Price Action & Weekly High Return Forecasts - Newser
Chart based analysis of Werewolf Therapeutics Inc. trends2025 AllTime Highs & Daily Profit Focused Screening - Newser
How sentiment analysis helps forecast Werewolf Therapeutics Inc.2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
Research Analysts Offer Predictions for HOWL Q3 Earnings - MarketBeat
Institutional scanner results for Werewolf Therapeutics Inc.2025 Market Overview & Weekly Market Pulse Updates - Newser
Detecting price anomalies in Werewolf Therapeutics Inc. with AIMarket Movement Recap & Weekly Market Pulse Alerts - Newser
What moving averages say about Werewolf Therapeutics Inc.Day Trade & Capital Efficiency Focused Strategies - Newser
Risk adjusted return profile for Werewolf Therapeutics Inc. analyzed2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - Newser
Applying Elliott Wave Theory to Werewolf Therapeutics Inc.July 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
How to interpret RSI for Werewolf Therapeutics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - Newser
Backtesting results for Werewolf Therapeutics Inc. trading strategiesJuly 2025 Weekly Recap & Fast Entry and Exit Trade Plans - Newser
What Fibonacci levels say about Werewolf Therapeutics Inc. reboundJuly 2025 Fed Impact & Advanced Technical Analysis Signals - Newser
Does Werewolf Therapeutics Inc. fit your quant trading modelJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
What momentum shifts mean for Werewolf Therapeutics Inc.Quarterly Trade Review & Safe Capital Investment Plans - Newser
Sector ETF performance correlation with Werewolf Therapeutics Inc.Breakout Watch & Weekly High Return Stock Forecasts - Newser
Is it time to cut losses on Werewolf Therapeutics Inc.Quarterly Portfolio Review & Fast Gain Stock Tips - Newser
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthPortfolio Return Report & Low Risk High Win Rate Picks - Newser
Combining price and volume data for Werewolf Therapeutics Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Will Werewolf Therapeutics Inc. bounce back from current supportJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Can Werewolf Therapeutics Inc. hit a new high this monthWeekly Stock Report & Daily Oversold Bounce Ideas - Newser
Research Analysts Set Expectations for HOWL Q1 Earnings - MarketBeat
Regression analysis insights on Werewolf Therapeutics Inc. performanceQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Analyzing Werewolf Therapeutics Inc. with risk reward ratio charts2025 Performance Recap & AI Driven Stock Reports - Newser
Volume spikes in Werewolf Therapeutics Inc. stock – what they meanPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Werewolf Therapeutics Inc Stock (HOWL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
1.13%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):